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Abstract 
 
It is known that elderly people suffering from heart disease can have memory problems. The 
hippocampus is the part of the brain that is essential for memory formation and is one of the 
areas that is most vulnerable to cerebral hypoperfusion. Long-term potentiation is widely 
accepted as the cellular basis for memory. Upregulation of glutamate receptors of the α-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and N-methyl-D-aspartate 
(NMDA) type in the synaptic membranes is important to make the synapses more efficient 
during long-term potentiation. While animal models of acute global or focal brain ischemia 
have been widely investigated, the brain effects caused by a dysfunctional heart have been 
insufficiently studied, in particular with respect to cellular and molecular mechanisms that 
link heart failure to cognitive impairment. 
 
To address the issue of a relation between heart failure and cognitive impairment, we have 
used a mouse model with specific, inducible expression of the mutUNG1enzyme in the heart. 
The mutUNG1 enzyme generates mitochondrial DNA damage in the form of 
apurinic/apyrimidinic sites which leads to mitochondrial impairment in cardiomyocytes and 
ultimately a dysfunctional heart. This gives the opportunity to study possible changes in the 
brain of a chronic heart failure mouse model. The aim of this thesis was to investigate 
whether a dysfunctional heart affects the expression of AMPA and NMDA receptors in the 
hippocampus, which would provide a possible explanation to the memory deficits 
experienced by patients suffering from heart disease. 
 
Quantitative polymerase chain reaction was used to quantify the gene expression of AMPA 
and NMDA receptors. Quantitative electron microscopy, by the use of postembedding 
immunogold labelling, was used to study the number of AMPA and NMDA receptors present 
in excitatory synapses of the hippocampus, as well as synaptic morphology in the form of 
postsynaptic density length. 
 
The results obtained by qPCR showed large variations in gene expression within both groups, 
but no significant difference was found between them. Quantitative electron microscopy 
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showed no significant differences in number of receptors at the protein level and in the length 
of postsynaptic densities. 
 
These results show that acute heart failure as induced in this mouse model may not be 
sufficient to have an impact on the brain. Nonetheless, the use of a different chronic heart 
failure model in future studies could show a link between heart failure and cognitive decline. 
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1 Introduction 
1.1 Effects of heart failure on cognitive function 
 
The heart is pumping blood out to the whole body, supplying all the cells with nutrients and 
oxygen. It consists of muscle cells called cardiomyocytes which make the heart contract 
approximately 100 000 times per day. Apart from the heart, the brain is the organ with the 
highest blood supply. 15-20% of cardiac output goes to the brain, indicating the great need for 
glucose and oxygen required to maintain neuronal metabolism. Too low cerebral blood flow  
results in ischemia, rapidly leading to cell damage or cell death.  
 
Heart failure (HF), i.e. the heart's pumping power is weaker than normal, is an increasing 
health problem that affects 1-2% of the global population and increases dramatically when 
surpassing the age of 65 (Dardiotis et al., 2012). HF has been shown to affect several 
cognitive abilities like attention, learning ability, memory, language, visuospatial function, 
executive function and psychomotor speed (Vogels et al., 2007a, 2007b). More than 40% of 
patients who underwent coronary artery bypass experience cognitive decline that continues 
after five years (Newman et al., 2001). There is also an ongoing debate on whether 
Alzheimer's disease is a neurodegenerative or cardiovascular disease, or a combination of 
both (de la Torre, 2004; Lee et al., 2014). Many of the cognitive functions, especially memory 
and learning, are related to the hippocampus, which has been shown to be vulnerable to 
ischemia (Schmidt-Kastner and Freund, 1991; Zhu et al., 2012). Since there seems to be a link 
between HF and cognitive decline, a great effort has recently been undertaken trying to 
uncover the underlying mechanisms. 
1.2 Neurons 
 
Neurons are one of the two primary cell types that constitute the nervous system, the other 
being glial cells. While the primary function of neurons is to transmit electrical signals, glial 
cells possess more diverse roles, like initiating immune responses (microglia), enhancing the 
electrical signals of neurons (oligodendrocytes) and regulating the chemical content of the 
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extracellular environment (astrocytes). A classical neuron consists of a dendritic tree, the 
soma and an axon (figure 1.1). Neurons are electrically excitable and connect to each other 
through specialized structures called synapses, allowing them to communicate. A synapse is 
typically located between a presynaptic axon terminal and a postsynaptic dendritic spine and 
is the release site for neurotransmitters. Different kinds of neurotransmitters can affect the 
postsynaptic neuron in different ways. Neurotransmitters that make the postsynaptic neuron 
more likely to generate electrical signals are said to be excitatory, whereas neurotransmitters 
that make postsynaptic neuron less likely to genereate electrical signals are said to be 
inhibitory. The effect is not dependent on the neurotransmitter itself, but on the type of 
receptor it binds to. Simple neurotransmitters, like single amino acids, are synthesized in the 
axon terminals, while larger neurotransmitters, like peptides and proteins, are synthesized in 
the soma and transported in vesicles all the way to the axon terminal. 
 
 
Figure 1.1 Illustration of neuron structure. A presynaptic neuron (yellow) and a postsynaptic neuron 
(blue) are shown. Action potentials are generated at the border between the soma and axon, at the axon 
hillock, from where it propagates down the axon until it reaches the axon terminal. Neurotransmitters 
are then released from the axon terminal, into the synaptic cleft, and bind to neurotransmitter receptors 
on the dendritic spine of the postsynaptic neuron. Depending on the type of receptor, the affect can 
either be excitatory or inhibitory. 
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1.3 The chemical synapse 
 
The chemical synapse is a special membrane junction for neuronal communication. It consists 
of three components (figure 1.2): 
1) The presynaptic membrane, which is part of the axon terminal and site for 
neurotransmitter release. 
2) The synaptic cleft, which is the space between the pre- and postsynaptic neurons 
where neurotransmitters are released into. 
3) The postsynaptic membrane, which is located on one of the dendrites of the 
postsynaptic neuron and contains neurotransmitter receptors. 
 
 
Figure 1.2 Illustration of a chemical synapse. These synapses are often encompassed 
by astrocytes, which regulate several aspects of the synapse, i.e. ion and water 
homeostasis and neurotransmitter uptake. The width of the synaptic cleft is 
approximately 20 nm. 
 
 
Neurotransmitters are stored in vesicles located in the axon terminal, near the presynaptic 
membrane. When released into the synaptic cleft by exocytosis, the neurotransmitters will 
bind to receptors on the postsynaptic membrane in an area called the postsynaptic density 
(PSD) due to the many densely packed receptors and associated proteins located there. 
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Depending on the type of receptor, the binding of transmitter can initiate an excitatory 
postsynaptic potential (EPSP) or an inhibitory postsynaptic potential (IPSP). In this way, the 
electrical signal in the presynaptic neuron is transformed into a chemical signal that can either 
promote or prevent the postsynaptic neuron from generating a new electrical signal. The 
strength of the signal is determined by the amount of transmitter released, the density of the 
receptors and the rate of diffusion of the transmitter out of the synaptic cleft, which is 
governed by the activity of inactivating transporters. Simple neurotransmitters, like single 
amino acids, are recycled from the synaptic cleft by transportation into astrocytes and back to 
the neurons or by direct uptake into presynaptic terminals, whereas larger peptides and 
proteins are degraded by proteases. 
1.4 Glutamate 
 
In addition to being an important amino acid for protein synthesis, glutamate is the most 
abundant neurotransmitter in the brain. Nearly all excitatory synapses in the brain are 
glutamatergic. After release into the synaptic cleft, the glutamate has to be removed. 
Prolonged exposure to glutamate may initiate neuronal cell death by necrosis or apoptosis due 
to excessive influx of Ca2+, a phenomena termed excitotoxicity (Ankarcrona et al., 1995; 
Arundine and Tymianski, 2003). The glutamate can be removed by the synaptic cleft by direct 
reuptake into the presynaptic terminal for reuse as neurotransmitters or transported into the 
postsynaptic dendrite (Gundersen et al., 1993; Takahashi et al., 1996). However, most of the 
glutamate is taken up by astrocytes where it is converted to glutamine (Laake et al., 1995). 
The amino acid glutamine is released into the extracellular space and subsequently 
transported into the presynaptic terminal where it is converted back to glutamate. This 
glutamate-glutamine cycle contributes to prevent the neurons from depleting their glutamate 
storage. Once inside the presynaptic terminal, the glutamate is transported into vesicles ready 
for another round of exocytosis (Naito and Ueda, 1983). 
1.5 Glutamate receptors 
 
Glutamate receptors are divided into two types: ionotropic and metabotropic. Whereas the 
latter are G-protein coupled receptors and operates through second messengers, the ionotropic 
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receptors form cation channels. The ionotropic glutamate receptors are divided into three 
families based on their selective agonists which mimic the effect of glutamate binding: α-
Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), N-methyl-D-Aspartate 
(NMDA) and kainate receptors (table 1.1). They are heteromeric assemblies of four subunits 
(figure 1.3), each affecting the biophysical properties of the receptor (Traynelis et al., 2010). 
 
Receptor family Subunit Gene 
AMPA 
GluA1 
GluA2 
GluA3 
GluA4 
GRIA1 
GRIA2 
GRIA3 
GRIA4 
NMDA 
NR1 
NR2A 
NR2B 
NR2C 
NR2D 
NR3A 
NR3B 
GRIN1 
GRIN2A 
GRIN2B 
GRIN2C 
GRIN2D 
GRIN3A 
GRIN3B 
Kainate 
GluK1 
GluK2 
GluK3 
GluK4 
GluK5 
GRIK1 
GRIK2 
GRIK3 
GRIK4 
GRIK5 
 
Table 1.1 The different glutamate receptors and their subunits. 
 
There are four AMPA receptor subunits: GluA1, GluA2, GluA3 and GluA4. AMPA receptors 
are diheteromeric, usually consisting of two GluA2 subunits and two of a different subunit. 
The ion channel of the receptor opens and closes quickly and has high permeability to Na+, 
thus rapidly depolarizing the neuron. Due to the fast kinetic properties, AMPA receptors 
allow for high temporal precision and short latency of action potential initiation (Andersen et 
al., 2007, p. 251). The primary transcript of GluA2 undergoes RNA editing of a single 
glutamine to arginine (Sommer et al., 1991). This editing takes place in the pore-loop segment 
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and makes the AMPA receptor impermeable to Ca2+, a property important for the regulation 
of synaptic plasticity like long-term potentiation (LTP) and long-term depression (LTD). 
 
In addition to Na+, NMDA receptors are permeable to Ca2+. Ca2+ is an important second 
messenger that can initiate synaptic changes when entering the postsynaptic dendrite. Binding 
of glutamate alone is not sufficient to activate the NMDA receptor, as this also requires 
binding of glycine and a partial depolarization of the postsynaptic membrane. At resting 
potential, when the neuron does not receive input from other neurons, the cation channel of 
the NMDA receptor has a voltage-dependent Mg2+ block. A partial depolarization of the 
membrane, obtained by the activation of AMPA receptors, is required to repel the Mg2+ ion. 
The NMDA receptors are therefore said to function as coincidence detectors, as they will only 
open when several input signals are received closely in time (Seeburg et al., 1995). Compared 
to AMPA receptors, NMDA receptors have higher affinity for glutamate, slower activation 
kinetics and stay open for a longer time. There are seven NMDA receptor subunits: NR1, 
NR2A, NR2B, NR2C, NR2D, NR3A and NR3B. The NMDA receptors are predominantly 
diheteromeric, consisting of two NR1 subunits and two identical NR2 subunits. However, 
triheteromeric receptors are also expressed in certain brain areas, like the hippocampus (Tovar 
et al., 2013). The NR1 subunit is crucial for the NMDA receptor to function, as this subunit 
contains the binding site for glycine, and all NMDA receptors contain two of them. The NR2 
subunits contain the binding site for glutamate. The diversity of NR2 subunits gives rise to 
different NMDA receptors, each having unique biophysical properties (Cull-Candy and 
Leszkiewicz, 2004). The NR2B subunit, for instance, has slower decay kinetics than the 
NR2A subunit and will therefore cause the channel to stay open longer. The distribution of 
NMDA receptor subunits is not constant, as the ratio of NR2 subunits has been shown to 
change in developing brain areas (Monyer et al., 1994). The NR3 subunits contain binding 
site for glycine, and NMDA receptors assembled from NR1 and NR3 subunits are activated 
by glycine only and are therefore not considered as glutamate receptor (Andersen et al., 2007, 
p. 253). 
 
Less is known about the functional role of kainate receptors, which are located in other 
subcellular compartments in addition to the PSD. While AMPA and NMDA receptors 
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mediate most of the basal excitatory transmission, kainate receptors possess more diverse 
roles depending on their subunit composition and cellular localization (Carta et al., 2014). The 
EPSPs generated by kainate receptors are generally smaller compared to the EPSPs generated 
by AMPA receptors. 
 
 
Figure 1.3 Structure of an ionotropic glutamate receptor and its subunits. The receptor subunit has 
four transmembrane domains (TM I-IV). The N-terminus is extracellular, while the C-terminus is 
intracellular because of the second transmembrane domain not fully traversing the membrane. The 
ligand binding site is located between the N-terminal loop and the loop connecting transmembrane 
domains III and IV. Most ionotropic glutamate receptors are diheteromeric assemblies of four 
subunits. 
 
1.6 NMDA receptor-dependent LTP and LTD 
 
Long-term potentiation (LTP) and long-term depression (LTD), two forms of synaptic 
plasticity, are thought to be the cellular mechanisms behind learning and memory. Different 
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types of LTP and LTD exist, but those occurring in the Schaffer collateral pathway of the 
hippocampus are classified as NMDA receptor-dependent and are the most studied form 
(Lüscher and Malenka, 2012). While both LTP and LTD require the influx of Ca2+ through 
NMDA receptors, the distinguishing factor seems to be the degree of influx. A large increase 
in intracellular Ca2+ promotes LTP, while a small increase promotes LTD. 
 
Several methods to induce LTP and LTD have been used, e.g. frequency-specific presynaptic 
firing patterns and spike-timing-dependent plasticity (Lüscher and Malenka, 2012). The exact 
mechanisms during learning and memory formation in the intact animal are not fully 
understood. Nonetheless, LTP and LTD exhibit properties important for the formation of 
memories such as input specificity, associativity and cooperativity (Kandel et al., 2012). 
 
LTP is dependent on the activation of Ca2+-dependent protein kinases (figure 1.4a). 
Ca2+/calmodulin-dependent kinase II (CaMKII) possesses a central role, as this kinase is 
known to phosphorylate AMPA receptors (Derkach et al., 1999), thereby enhancing their 
conductance, and is also needed for the insertion of additional AMPA receptors in the 
postsynaptic membrane (Hayashi et al., 2000). These mechanisms lead to strengthening of the 
synapse and thereby results in enhanced signal transmission between the neurons. The 
duration of LTP varies from seconds to months or longer (Abraham et al., 2002). The early 
phase of LTP is maintained by protein kinases, while the late phase requires synthesis of new 
proteins, either through translation of pre-existing mRNA located in the postsynaptic spine or 
by gene transcription (Abraham and Williams, 2003).  
 
LTD, on the other hand, is dependent on protein phosphatases, which reverse the effect by 
dephosphorylating the AMPA receptors and promoting receptor endocytosis (figure 1.4b). It 
has been shown that two phosphatases involved in LTD, calcineurin and protein phosphatase 
1 (PP1), have higher Ca2+ affinity than CaMKII (Lisman, 1989), which provides an 
explanation for the different Ca2+ levels required for LTP and LTD. 
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Figure 1.4 Schematic drawing of: a) NMDA receptor-dependent LTP. A rapid increase of Ca2+ 
leads to activation of protein kinases. This results in enhanced AMPA receptor conductivity and 
insertion of AMPA receptors into the postsynaptic membrane. Only the early phase of LTP is included 
in the drawing. b) NMDA receptor-dependent LTD. A slow increase in Ca
2+
 activates protein 
phosphatases. This leads to the reversal of the effects underlying LTP. 
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1.7 The hippocampus 
 
The hippocampus is canonical model for the study of communication between neurons due to 
its intrinsic neural circuit. Most of the research regarding long-term potentiation (LTP) has 
been carried out in the hippocampus. Its main function is thought to be that of memory 
consolidation and spatial navigation. The hippocampus is part of the hippocampal formation 
and is located in the medial temporal lobe, one in each hemisphere. It consists of a tightly 
packed layer of pyramidal neurons that projects through three subfields termed CA3, CA2 and 
CA1 (Andersen et al., 2007, p. 37). In addition, there are many different inhibitory neurons 
that regulate the activity of the pyramidal neurons. The subfields are further divided into 
different layers, or strata, depending on where the different projections connect along the 
dendritric tree. 
1.8 Hippocampal function: memory and spatial 
navigation 
 
The hippocampus is required for the formation of declarative memories. Declarative memory 
can be divided into episodic memory and semantic memory (Tulving, 1972). Episodic 
memory is the recollection of events from an individual's own life where contextual factors 
like place and time are central. Semantic memory is general knowledge, or facts, about the 
world. Damage to the hippocampus indicates that its function is to consolidate this declarative 
memory for permanent storage in other cortical areas (Eichenbaum, 2013). Supporting this 
view is the observation of descending activity in the hippocampus when subjects try to recall 
more and more remote memories (Smith and Squire, 2009). The surgical removal of two 
thirds of each of the hippocampi in patient H.M. was the first case that proved the link 
between this brain area and its function to memory (Scoville and Milner, 1957). H.M. could 
not form new episodic or semantic memories after the surgery, but could form non-declarative 
(non-conscious) memories like motor skills, meaning that this type of memory is not 
dependent on the hippocampus. He did also show normal “working memory”, which is the 
ability to hold multiple pieces of information in mind while focused. However, several studies 
have now shown that the hippocampus is involved in working memory as well (Axmacher et 
al., 2009; Ben-Yakov and Dudai, 2011). 
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Hippocampus is a lso cruc ia l for spat ia l navigat ion. The pyramida l neur ons o f the 
hippocampus function as «place cells», whose activity depend on specific locations in an 
environment. Together with other evidence, this observation led to the assumption that 
hippocampus functions as a cognitive map (O’Keefe and Nadel, 1978). The place cells 
receive input from other types of neurons in the hippocampal formation, e.g. the «grid cells» 
in the enthor ina l cortex, which fire in a fixed gr id like pattern, independent of the 
environment, when the rat is moving around (Hafting et al., 2005). The place fields of the 
hippocampus have been speculated to contribute with a context of space to episodic 
memories, e.g. where a part icular event took p lace (S mith and Mizumori, 2006).   
 
The role of the NMDA receptor has been strongly linked to all these properties, suggesting 
LTP and LTD as the cellular basis. Knockout of the NR1 subunit in CA1 pyramidal neurons 
in mice results in larger and more diffuce place fields, as well as uncorrelated activity 
(McHugh et al., 1996). Furthermore, blockage of NMDA receptors disrupted the long-term 
stability of place fields (Kentros et al., 1998). Upregulat ion of the NR2B subunit in 
hippocampus of transgenic mice enhanced LTP in the Schaffer collateral pathway because 
NR2B contributes to a longer opening time of NMDA receptors (Tang et al., 1999). The 
transgenic mice performed better at object recognition tasks, fear conditioning and the Morris 
water maze, which is a test used to study spatia l learning and memory in rodents. 
1.9 Intrinsic circuit of the hippocampus 
 
The intrinsic circuit of the hippocampus is illustrated in figure 1.5. Axons from the enthorinal 
cortex project to the granule cell layer of the dentate gyrus. The mossy fibers of the granule 
cells project to the CA3 pyramidal neurons of the hippocampus, which in turn transmit signals 
through their Schaffer collateral fibers to CA1 pyramidal neurons. CA1 pyramidal neurons 
project to the subiculum and enthorinal cortex, thus enclosing the circuit and establishing 
what can be considered as a synaptic loop. Additionally, both CA3 and CA1 pyramidal 
neurons receive input directly from the enthorinal cortex, and CA3 has an 
associational/recurrent connection where axons project back to the CA3 subfield. 
 
12 
 
 
 
Figure 1.5 A schematic drawing of the intrinsic circuit of the hippocampal formation. The 
hippocampal formation includes the dentate gyrus, the hippocampus, the subicular complex and the 
enthorinal cortex (Andersen et al., 2007, p. 37). The subicular complex, consisting of the subiculum, 
presubiculum and parasubiculum, is not depicted here. It is located between the CA1 area and 
enthorinal cortex and is the the major extrinsic pathway out of the hippocampal formation to other 
cortical and subcortical areas. Figure from Neves et al., 2008. 
 
1.10  The Schaffer collateral pathway 
 
The pyramidal neurons of the CA1 subfield are slightly smaller than other pyramidal neurons. 
They are also more homogenous, as the size of the cell somas and length of the dendritic trees 
do not differ significantly (Andersen et al., 2007, p. 68). The axons traverse apical to the 
somas in an area called the alveus. 
 
The major input to CA1 comes from CA3 and is termed the Schaffer collateral pathway. The 
Schaffer collaterals are axons from CA3 pyramidal neurons and project into the stratum 
radiatum of CA1, which is the layer right next to the pyramidal cell somas on the apical side. 
Here, the apical dendrites can be seen as thick stem dendrites with a lot of glutamatergic 
synapses connected to their spines (figure 1.6). 
 
Most of the Schaffer collateral-CA1 synapses contain both AMPA and NMDA receptors. 
However, some contain only NMDA receptors and do not respond to incoming signals from 
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presynaptic terminals under normal conditions (Isaac et al., 1995). They are therefore termed 
«silent synapses». The number of silent synapses decreases with age, and LTP is thought to 
be the mechanism for «unsilencing» these synapses by insertion of AMPA receptors. It has 
also been shown that the PSD of silent synapses has a shorter diameter compared to the PSD 
of synapses containing NMDA receptors, which may be due to the lack of AMPA receptors 
(Takumi et al., 1999). 
 
 
Figure 1.6 A cropped view of stratum radiatum in CA1 by electron microscopy. Green = stem 
dendrite (d), red = presynaptic terminal (t), blue = dendritic spine (s). The PSD can be seen as a dark 
«cloud» on the postsynaptic membrane due to all the protein complexes located there, making it 
electron-dense. The small round circles are vesicles (v) containing neurotransmitters (glutamate). 
Mitochondria (m) can be seen as dark circles with infoldings of their double membrane. The upper 
right corner shows a magnified view of the synaptic cleft with 10 nm gold particles (red arrows) 
coupled to antibodies recognizing ionotropic glutamate receptors in the PSD (length of PSD enclosed 
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by black arrow heads). Gold particles outside the PSD may be due to unspecific binding of the 
antibody or anterograde transport of receptors along the dendrites. 
 
1.11  Effects of heart failure on the hippocampus 
 
Hippocampus, and especially the CA1 subfield, has been shown to be particularly vulnerable 
to ischemia (Schmidt-Kastner and Freund, 1991; Zhu et al., 2012). It is therefore a suitable 
area to study changes in the brain that might arise due to HF, and also because it is known to 
be an important brain area for many the cognitive deficits resulting from HF. Not many 
studies have examined synaptic changes specifically related to HF or other cardiovascular 
diseases. However, in one study, data obtained by electron microscopy showed increased 
length and thickness of PSDs in stratum radiatum of CA1 shortly after ischemia (Kovalenko 
et al., 2006). Another study showed a switch in the expression of AMPA receptor subunits in 
CA1 following global ischemia, where the expression of the GluA2 subunit was reduced 
(Pellegrini-Giampietro, 1992). As previously mentioned, the GluA2 subunit is responsible for 
the Ca2+ impermeability of AMPA receptors. The reduction of GluA2 expression was linked 
to an increased influx of Ca2+ and a subsequent activation of the apoptotic pathway in 
neurons. This provides a possible explanation to why neurons in CA1 typically die first 
during ischemia compared to neurons in the other subfields of the hippocampus. The 
increased influx of Ca2+ and the presence of apoptotic markers, such as cytochrome c located 
in the cytosol, have been shown by others as well (Sugawara et al., 1999). 
1.12  Mitochondria and uracil-DNA glycosylase 1 
 
Mitochondria are energy supplying organelles found in most eukaryotic cells. The energy is 
supplied in the form of adenosine triphosphate (ATP), which is synthesized during oxidative 
phosphorylation. Although most of the mitochondrial genome has been relocated to the 
nucleus during evolution, some of the genes have been kept inside the mitochondrion, the so 
called mtDNA (Friedmann and Nunnari, 2014). The protein-encoding part of the mtDNA 
codes for proteins involved in the electron transport chain and ATP synthesis (Falkenberg et 
al., 2007). Proteins involved in replication, transcription and DNA repair of the mtDNA are 
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encoded in the nucleus. One of the DNA repair enzymes is uracil-DNA glycosylase (UNG). 
 
UNG is a DNA repair enzyme which recognizes uracil in DNA through its uracil-binding 
pocket located near one end of the DNA-binding groove. Its biological function is to prevent 
mutagenesis by cleaving the N-glycosylic bond of uracil and initiate the base excision repair 
(BER) pathway (Lindahl and Wood, 1999). Two versions of the UNG protein exist in the cell: 
UNG1, which is transported to mitochondria, and UNG2, which is transported to the nucleus 
(Slupphaug et al., 1993). The two UNG proteins are encoded by the same gene that has 
different promoters and undergoes alternative splicing (Nilsen et al, 1997). The C-terminal 
269 amino acids are identical, while their N-terminals are unique and function as a sorting 
signal for which organelle it translocates to. The human UNG1 version is translocated to 
mitochondria only, whereas the murine version is not as specific and translocates to 
mitochondria and the nucleus (Nilsen et al., 2000; Otterlei et al., 1998). UNG1 and UNG2 are 
expressed in different amounts depending on cell type. Neurons and cardiomyocytes, for 
example, contain a high proportion of mitochondria due to high energy demand and therefore 
express high levels of UNG1. 
1.13  mutUNG1 expressing heart failure mouse 
model 
 
The tremendous working capacity of the heart demands a very high energy supply in the form 
of ATP. In fact, approximately 30% of a cardiomyocyte's total volume is comprised of 
mitochondria (Barth et al., 1992). An inducible transgenic mouse model expressing a mutated 
version of human uracil-DNA glycosylase 1, mutUNG1, has previously been generated for 
studying heart cells with defect mitochondria (Lauritzen et al., 2014). In this model, a single 
amino acid has been substituted in the UNG1-enzyme's catalytic site, resulting in an enzyme 
that removes not only uracil, but also thymine, from DNA. The outcome is continuous 
induction of high levels of apurinic/apyrimidinic (AP) sites throughout the mtDNA leading to 
mtDNA damage and mitochondrial dysfunction. Mice with this phenotype typically live for 
roughly two months after induction, before dying from congestive heart failure. 
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By utilizing molecular biology tools like the Tet-on system, expression of mutUNG1 can be 
regulated both spatially and temporarily. Two genetic elements are involved: a reverse 
tetracycline transactivator (rtTA) and a responding Tet-promoter. The rtTA binds to the Tet-
promoter in the presence of doxycycline, a tetracycline analogue, which initiates transcription 
of mutUNG1 (figure 1.7). Therefore, by either adding or removing doxycycline from the 
mouse’s diet, one can turn on or off transcription, respectively. Expression of mutUNG1 will 
be limited to cardiomyocytes by having the transactivator gene under regulation of the myosin 
heavy chain α (MHCα) promoter. 
 
 
Figure 1.7 The mutUNG1 expressing heart failure model. Expression of mutUNG1 is under 
regulation of the Tet-on promoter. The transactivator, rtTA2, is required for gene transcription, but is 
only able to bind to the Tet-on promoter in the presence of doxycycline (Dox). Dox is given through 
the diet, and it is therefore easy to switch on and off the gene expression of mutUNG1. 
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1.14  Questions addressed 
 
A decline in cognitive abilities is linked to heart failure. Hippocampus is known to be 
involved in many of the cognitive functions affected, like memory, learning and spatial 
navigation. LTP and LTD are thought to be the cellular mechanisms of these functions, and 
alterations in expression of ionotropic glutamate receptors might provide a possible 
explanation to some of the cognitive deficits of heart failure patients. The CA1 subfield of the 
hippocampus has been widely studied when it comes to LTP and LTD, and it is also a brain 
area that is extra vulnerable to alterations in blood flow. In this thesis, a mutUNG1 heart 
failure mouse was therefore used as a model organism to address the following questions 
when comparing it to healthy wild type mice: 
 
1. Are there differences in gene expression of AMPA and NMDA receptor subunits in 
the hippocampus? This was addressed by quantitative polymerase chain reaction 
(qPCR). 
 
2. Are there differences in the number of AMPA and NMDA receptors and/or subunit 
composition at the protein level in Schaffer collateral-CA1 synapses showing 
immunogold labelling? This was addressed by quantitative postembedding 
immunogold electron microscopy. 
 
3. Are there morphological changes, in the form of PSD length, in the same Schaffer 
collateral-CA1 synapses showing immunogold labelling? This was addressed by 
postembedding immunogold electron microscopy. 
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2 Materials and methods 
2.1 Experimental animals 
 
 All experimental animals were four months of age at the time of death.  
 Hippocampus from three FVB/N wild type mice (ID 6, 33 and 39) and three 
transgenic mutUNG1 expressing FVB/N mice (ID 4, 42 and 98) were used to analyze 
gene expression by qPCR. 
 One half (sagittal cut) of a FVB/N wild type mouse was used to obtain protein 
homogenate to analyze antibody specificity by Western blot. 
 Hippocampi from six FVB/N wild type (ID 6233-03, 6234-02, 6235-02, 6236-02, 
6237-02 and 6238-02) and six transgenic mutUNG1 expressing FVB/N mice (ID 
6239-03, 6240-02, 6241-02, 6242-02, 6243-02 and 6244-02) were used to analyze 
protein expression and PSD length by postembedding immunogold electron 
microscopy. 
2.2 Reagents, solutions, kits and antibodies 
 
See appendix for all reagents, solutions, kits and antibodies that were used. 
2.3 Quantitative polymerase reaction (qPCR) 
 
qPCR was performed to check for differences in gene expression of AMPA and NMDA 
receptor subunits in the hippocampus of wild type and mutUNG1 expressing mice. The whole 
procedure is described below and comprises RNA isolation and quantification, 
complementary DNA (cDNA) synthesis and cDNA amplification. 
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2.3.1 RNA isolation from hippocampus 
 
Because brain tissue contains high amounts of lipid, the RNA isolation was performed using 
the RNeasy Lipid Tissue Mini Kit (QIAGEN, Netherlands), a kit designed for extracting 
RNA from fatty tissue. Hippocampal tissue (30 mg) from each mouse was transferred to 
separate Lysing Matrix D tubes, containing small ceramic beads, in combination with QIAzol 
Lysis Reagent. The tubes were inserted into a FastPrep-24™ Instrument (MP Biomedicals) 
and shaken for 40 seconds at a speed setting of 6 m/s. Chloroform was added for the 
separation of the homogenate into three phases after centrifugation: an upper, aqueous phase 
containing RNA, an interphase containing DNA, and a lower, organic phase containing 
proteins. The upper phase was transferred to a new eppendorf tube with the addition of 70% 
ethanol and subsequently transferred to a spin column placed in a collection tube. RNA will 
stick to the spin column's membrane after centrifugation. An additional step with DNase 
treatment was performed to get rid of any DNA that might have been transferred along. The 
membrane was then washed with ethanol-containing buffer, and the spin column was 
subsequently transferred to a new collection tube where RNA was eluted by adding RNase 
free water followed by centrifugation. 
2.3.2 Quantification and evaluation of RNA 
 
The amount of isolated RNA was measured by the use of a NanoDrop 2000c instrument 
(Thermo Scientific, USA), which measures the absorbance during exposure of the RNA 
solution to ultraviolet light at 260 nm. 1 µl of RNA was pipetted onto the pedestal before 
registering the quantification number. This was done twice for each sample, giving an 
average, and a third time if the two first measurements differed significantly. 
 
RNA quality was checked on a 1.5% agarose gel, containing ethidium bromide (EtBr). When 
bound to the RNA, EtBr emits fluorescence when exposed to UV-light. RNA, diluted in 
RNase-free water, together with loading buffer, were pipetted into six individual wells; one 
for each mouse sample. The gel was run for 40 minutes in 1X TAE buffer at 100 Volts for 
separating the RNA based on size. Fluorescence was detected during exposure by UV-light in 
a Gel DocTM EZ imager (Applied Biosystems, USA). 
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2.3.3 Complementary DNA (cDNA) synthesis 
 
cDNA was synthesized from total RNA using the High Capacity RNA-to-cDNA kit (Applied 
Biosystems, USA). 20 µl reaction mixtures containing 2 µg of RNA template, RT-buffer and 
RT Enzyme mix were set up according to manufacturer's protocol. In this reaction mixture, a 
mix of oligo(dT) primers and random primers were used. Oligo(dT) primers anneals 
specifically to the poly(A) tail of mRNA, and random primers are more efficient if the RNA 
contains secondary structures. The combination of both increase data quality. Reverse 
transcription PCR (RT-PCR) was performed on a GeneAmp® PCR System 9700 (Applied 
Biosystems, USA). The thermal cycling conditions were set to 37 °C for 60 min and 95 °C for 
5 min, required for transcription and denaturation respectively. 
2.3.4 Amplification of cDNA 
 
Quantitative amplification of cDNA was done by qPCR in combination SYBR green, 
allowing amplification to be observed in real time. SYBR green is not as specific as sequence-
specific fluorescent probes, as it will bind to all double-stranded DNA, whether it be the gene-
of-interest (GOI), pseudo genes or primer dimers. Specific primers is therefore of great 
importance in order to avoid false signs. Several primer pairs for each gene were obtained 
from http://mouseprimerdepot.nci.nih.gov/ and literature, and melting curve analysis was 
performed to determine the best suited primer pairs (table 2.1). The primer sequences were 
confirmed to be included in all splice variants of the genes by performing BLAST searches. 
 
Gene  Sequence (5’-3’) Length Tm GC % 
Gria1 F: CCTTTGGAGAACTGGGAACA 
R: GCTTTGTCACAACTCACGGA 
20 
20 
64.0 
64.0 
50.0 
50.0 
Gria2 F: CCTCTTGAAAACTGGGAGCA 
R: ATTTCGGGTAGGGATGGTTC 
20 
20 
64.2 
63.7 
45.0 
50.0 
Gria3 F: TCCAAAGATAGCATACACCC 
R: CACCAACCAGAACACCACTG 
21 
20 
62.6 
64.3 
47.6 
55.0 
Gria4 F: GAGCACTGCAGAAGGAGGTC 
R: CTGCCAACAGTTTTGCTGTG 
20 
20 
64.2 
64.5 
60.0 
50.0 
Grin1 F: TGGGCTTGACATACACGAAG 
R: GCCAGGAGGAGAGACAGAGA 
20 
20 
63.7 
63.8 
50.0 
60.0 
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Grin2a F: TGGAAGCTCCAAACTGGAAG 
R: GTGGCTCAGATGCTGGATTT 
20 
20 
64.2 
64.2 
50.0 
50.0 
Grin2b F: AGGTGGTGACGATGGAGAAG 
R: ATCCATGGGGGCTCATCTA 
20 
19 
64.2 
64.2 
55.0 
52.6 
Grin2d F: CCTGCCTTGAGCTGAGTGAG 
R: CCACGGAGAAGAATATCCGA 
20 
20 
65.3 
63.9 
60.0 
50.0 
Grin3a F: GACATGGGGAGCATCCGGCAG 
R: CTTCTGTCCTCAGCTCCTCCAC 
21 
22 
75.1 
66.5 
66.6 
59.0 
Gapdh F: TCGTCCCGTAGACAAAATGGT 
R: CGCCCAATACGGCCAAA  
21 
17 
52.4 
58.8 
47.6 
49.5 
 
Table 2.1 Primer pairs for qPCR. The mouse versions of the gene names are given. Gria = 
AMPA receptor subunit, Grin = NMDA receptor subunit. 
 
Expression levels of the following genes were analyzed: GluA1, GluA2, GluA3, NR1, NR2A, 
NR2B, NR2D and NR3A. The reaction plate setup included cDNA triplicates from each 
sample, standard curves for the GOI and reference gene (GAPDH) and no template controls. 5 
ng of cDNA was used as template, and a tenth fold dilution of 0.01 – 0.1 – 1 – 10 – 100 ng for 
the standard curves. Standard curves were created by pooling cDNA from all the samples, 
assuming that all the RT reactions were performed with the same efficiency. The volume in 
each well consisted of 10 µl SYBR green master mix, 0.2 µl forward primer, 0.2 µl reverse 
primer, 7.6 µl MQ water and 2 µl cDNA template, giving a total of 20 µl. The qPCR was 
performed on a StepOnePlusTM Real-Time PCR System (Applied Biosystems) with a two-
step cycling program of 40 cycles: denaturation at 95 °C for 15 sec and annealing/elongation 
at 60 °C for 1 min. Each program was ended with a melting curve analysis to ensure 
amplification of only one product (figure 2.1a). 
2.3.5 Normalization of data 
 
The standard curve method was used for analyzing the data. The number of amplification 
cycles required for SYBR green fluorescence to be detected over a defined threshold, the CT  
value, was presented in an amplification plot (figure 2.1b). Standard curves were generated 
for the GOI and an endogenous reference gene, Glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) (figure 2.1c). GAPDH was chosen as the reference gene, as it is a housekeeping 
gene and should be present at a consistent level across all samples, ensuring credibility of the 
data. If the expression of the reference gene differs across the samples, it might indicate 
pipetting errors or variability in the RT reaction efficiency. The CT  values, in combination 
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with the standard curve, were used to calculate gene copy numbers (figure 2.1d). The GOI's 
copy number was then divided by the copy number of GAPDH, normalizing the value. 
Calculations were performed in Microsoft Excel 2010 (Microsoft Corporation, USA). 
 
Figure 2.1 Graphical presentation of qPCR. a) Melting curve for the assessment of amplified product. 
Observation of a single peak indicates primer specificity in that only one product has been amplified. 
b) An amplification plot showing the number of amplification cycles needed to reach a defined 
threshold. This number of cycles is termed the CT value. c) An example of an amplification plot for the 
standard curve (four ten-fold dilutions being shown). d) Quantification of cDNA by the use of a 
standard curve. One standard curve for the GOI and one for the normalizing gene (GAPDH) is shown. 
The copy number obtained for the GOI is divided by the copy number obtained for GAPDH, 
normalizing the value. 
 
 
23 
 
2.3.6 Statistical analysis 
 
The two-tailed Mann-Whitney U test was used to analyze the data. It is as a more robust test 
than the student's t-test because of the sample size, which is too small to assume it is normally 
distributed. Difference in gene expression is presumed if P < 0.05. The analysis was 
performed in GraphPad Prism 6 (GraphPad Software, inc., USA). 
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2.4 Western blotting 
 
Western blotting was performed to check the specificity of the antibodies to be used for 
immungold labelling: anti-GluA1, anti-GluA2&3, anti-NR1, anti-NR2A&B. The whole 
protocol is described below. 
 
2.4.1 Protein isolation 
 
One half of a brain (sagittal cut) from wildtype mouse was transferred to a Lysing Matrix D 
tube. 1 ml RIPA buffer, containing protease inhibitor, was added. The RIPA buffer can be 
used for extraction of both soluble and membrane proteins. The tube was inserted into a 
FastPrep®-24 Instrument (MP Biomedicals, USA) and shaken at 6 m/s for 40 sec, before 
being put on ice for 2 hours, followed by centrifugation at 12100 x g for 8 min. The 
supernatant was then pipetted into a new eppendorf tube, excluding the fatty tissue at the 
bottom. A total of ~800 µl was obtained and aliquoted into 50 µl samples (stored at -80 °C). 
2.4.2 Protein quantification 
 
The amount of protein isolated was determined by using the BCA Protein Assay Kit (Pierce, 
Thermo Fisher Scientific, USA). This assay utilizes the biuret reaction, where cupric ions 
(Cu2+) are reduced to cuprous ions (Cu+) in the presence of protein, followed by a second 
reaction in which the resulting cuprous ions react and form complexes with bicinchoninic acid 
(BCA). The BCA-Cu+ complexes yield a purple colour, showing the strongest absorbance at 
562 nm that is linear with increasing protein concentrations. 
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Stock solution BSA, 2mg/ml 1% SDS Buffer Concentration 
Std 1 60 μl stock - 2000 μg/ml 
Std 2 60 μl stock 60 μl 1000 μg/ml 
Std 3 84 μl stock 140 μl 750 μg/ml 
Std 4 20 μl stock 60 μl 500 μg/ml 
Std 5 20 μl stock 140 μl 250 μg/ml 
Std 6 40 μl Std 5 60 μl 100 μg/ml 
Std 7 20 μl Std 5 80 μl 20 μg/ml 
Std 8 - 60 μl 0 μg/ml 
 
Table 2.2 Standard curve setup for protein quantification. 
 
A flat bottom 96-well microplate (Thermo Scientific, USA) was used for setting up the BCA 
assay. A standard curve was prepared by diluting bovine serum albumine (BSA) with 1% 
Sodium dodecyl sulfate (SDS) buffer (table 2.2). The isolated protein homogenate was diluted 
1:5, 1:10 and 1:20. Standards, undiluted and diluted protein samples were pipetted in 10 μ l 
triplicates. The BCA assay reagents were mixed 50:1 (24.5 ml of reagent A with 500 μl of 
reagent B), and 200 μl of this reagent mixture was added to each well. The microplate was 
covered with a thin plastic film and mixed for 15 min on a rotary shaking table, before being 
incubated at 37 ｰC for 30 min. Absorption was then measured at 562 nm by the use of a 
Spectrophotometer (SPECTROstar, Omega, BMG Labtech, Germany). The standard curve 
was used to calculate the protein concentration in the unknown samples (Appendix F). 
2.4.3 Separation of proteins by SDS-PAGE 
 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was used for the 
separation of proteins based on the size alone. SDS is an anionic detergent that linearizes 
proteins and imparts a negative charge. The longer the linear protein is, the more negative 
charge it has. The original conformation and charge of the protein, which would otherwise 
have affected the mobility, are therefore excluded. 
 
The protein homogenate were diluted to approximately 2 µg/µl with sample buffer, before 
being mixed properly and incubated at 60 °C for 5 min (appendix F). Preparation of 1X 
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Running buffer was carried out by adding 450 ml of distilled water to 50 ml of 10X Running 
buffer. A 4-20% CriterionTM Precast Gel was prepared by removing the white tape at the 
bottom of the gel cassette, for later allowing the electric current to go through, and placed into 
a CriterionTM Cell tank (Bio-Rad Laboratories, USA). Approximately 50 ml of the running 
buffer was added to the upper buffer chamber, covering the wells, before gently removing the 
comb from the top of the gel. The wells were washed by pipetting running buffer into them. 5 
ul of the protein standard ladder and different volumes of the prepared samples (10, 20 and 40 
ul) were pipetted by the use of a micropipette with gel-loading tips. The remaining loading 
buffer, approximately 400 ml, was poured into the lower buffer chamber. The casset's lid was 
put on top, and the leads were plugged into the power source. The electrophoresis was run for 
1 hour on 200 V. 
2.4.4 Electrophoretic transfer of proteins 
 
Electrophoretic transfer of proteins is the process of transferring, or “blotting”, proteins from 
the separating acrylamide gel onto a solid support matrix by the use of an electric field. Due 
to the treatment with SDS, the negatively charged proteins will migrate towards the anode. 
The support matrix used here is a nitrocellulose membrane, which has high protein-binding 
affinity and can be used with a variety of detection methods. The transfer can either be “semi-
dry” or “wet”. The latter was carried out, in which the blotting takes place in a tank filled with 
blotting buffer. Wet transfer yields a higher transfer efficiency of bigger proteins. 
 
The gel cassette was opened with a gel knife, and the upper and lower parts of the gel were 
cut away. A “blotting sandwich” was prepared by stacking filter pads, filter paper and the gel, 
together with a nitrocellulose membrane, in the middle (figure 2.2), before being placed in a 
plastic cassette. All parts were soaked in blotting buffer before assembly, and a small roller 
tool was used to remove air bubbles between the gel and the nitrocellulose membrane. Since 
the current generates a lot of heat, a cooling element was placed in the back, and a magnet 
was put in the tank, which was placed on a magnetic stirrer. The CriterionTM Blotter tank 
(Bio-Rad Laboratories, USA) was filled with blotting buffer and the lid was put on. 50 V was 
applied for 2 hours. 
 
After the run, the sandwich was opened, and the nitrocellulose membrane was taken out by 
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carefully removing the fiber pads. The membrane was left to air dry on a piece of paper. 
 
 
 
Figure 2.2 Illustration of a “blotting sandwich”. The proteins, having a negative charge due to 
treatment with SDS, will travel towards the anode when applying an electrical field. 
 
 
2.4.5 Incubation with antibodies 
 
The nitrocellulose membranes were incubated in blocking solution containing Tris-buffered 
saline Tween (TBST) w/ 4% bovine serum albumin (BSA)) for 1 hour on an electric shaker, 
before being rinsed in TBST for 3x10 min. This step blocks the protein-free areas of the 
membrane, preventing antibodies from binding to the membrane and thereby reducing the 
background labelling. Primary and secondary antibodies were diluted in different 
concentrations of less concentrated blocking solution (TBST w/1% BSA): 
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Primary antibodies: 
 Rabbit Anti-GluA1 IgG   1:200 
 Rabbit Anti-GluA2&3 IgG   1:1000 
 Mouse Anti-NR1 IgG    1:300, 1:900, 1:2700 
 Rabbit Anti-NR2A&B IgG   1:1000 
 
 Secondary antibodies: 
 Donkey anti-rabbit IgG, HRP-linked  1:20 000 
 Rabbit anti-mouse IgG, HRP-linked  1:20 000 
 
The nitrocellulose membranes were incubated overnight in primary antibody solution at room 
temperature (negative controls in blocking solution without primary antibody) on a fixed 
angle platform rocker, before being rinsed in TBST for 3x10 minutes. The membranes, 
including negative controls, were thereafter incubated in secondary antibody solution for 1 
hour at room temperature on an electric shaker, before being rinsed in TBST for 3x10 
minutes. 
2.4.6 Detection and visualization of proteins 
 
The detection of protein bands was achieved by chemiluminescence. SuperSignal® West 
Dura Extended Duration Substrate kit (Pierce, Thermo Fisher Scientific, USA) was used to 
detect the blotted proteins. The nitrocellulose membranes were incubated for 5 min in 
enhanced chemiluminescence (ECL) substrate (2 ml of Stable Peroxidase Buffer mixed with 2 
ml of Luminol/Enhancer Solution). Horseradish peroxidase, which is linked to the secondary 
antibody, will in contact with its substrate catalyze a reaction that yields a chemiluminescent 
product which emits light. The emitted light was detected using a digital imaging system 
(Image Reader LAS-3000, Fujifilm, Japan). 
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2.5 Immunogold electron microscopy 
 
Postembedding immunogold labelling, in combination with transmission electron microscopy, 
was used to quantitate the average number of ionotropic glutamate receptor subunits in 
Schaffer collateral-CA1 synapses of the hippocampus and to measure the PSD length of those 
synapses that did show labelling. 
 
The tissue fixation and dissection, lowicryl embedding and sectioning were performed by 
laboratory workers at the Electron Microscopic Laboratory, Department of Anatomy, 
University of Oslo (Norway). The ultrathin sections were received ready for immunogold 
labelling. The protocols are nevertheless included here to explain the whole method. 
2.5.1 Tissue fixation and dissection 
 
The mice were anesthetized according to animal welfare laws followed by transcardial 
perfusion with fixative containing 0.1% glutaraldehyde and 4% formaldehyde in phosphate 
buffer (PB). After tissue fixation, the hippocampi were dissected out into 1 mm3 specimens, 
followed by cryoprotection in increasing concentration of glycerol: 10%, 20% and 30% in PB 
for 30 minutes at room temperature each time and finally at 4 °C over night. 
2.5.2 Lowicryl embedding 
 
The specimens were embedded in Lowicryl HM20, which is a water insoluble, acrylic resin, 
allowing the specimens to be sectioned into ultrathin sections. The specimens were first 
quickly frozen in liquid propane. This rapid cooling avoids the formation of ice crystals 
within the tissue. The specimens were then dehydrated and treated with 1,5% uranyl acetate in 
anhydrous methanol at -90 °C for 30 hours, followed by a stepwise temperature increase of 
4 °C from -90 °C to -45 °C. Dehydration was followed by infiltration of Lowicryl HM20, a 
water-insoluble acryl-based resin, and left overnight before being exposed to UV-light at -
45 °C for 24 hours. The UV-light leads to polymerization of the resin, making it hard. This 
was followed by a stepwise temperature increase of 1 °C until 0 °C was reached. Exposure to 
UV-light was then continued for 35 hours. After polymerization, the resin blocks were stored 
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at room temperature. 
2.5.3 Ultrathin sectioning 
 
The resin blocks were trimmed to get rid of excessive resin. The trimmed resin blocks were 
then cut with a diamond knife into ultrathin sections of approximately 90 nm on a microtome 
(Reichert Ultracut S-2.GA-E-12/92, Leica Microsystems, Germany). This thickness is 
required when looking at the tissue in an electron microscope. A larger thickness will prevent 
the electron-beam from passing through the tissue, thus making it impossible to visualize the 
tissue morphology. The ultrathin sections were transferred onto nickel mesh grids and left at 
room temperature. 
2.5.4 Postembedding immunogold labelling 
 
Before starting with immunogold labelling, the primary and secondary antibody solutions 
were prepared by diluting the primary antibodies in Tris-buffered saline Triton (TBST) w/ 2% 
human serum albumin (HSA) and secondary antibodies in TBST w/ 2% HSA and 
polyethylene glycol (PEG) added. 
 
Primary antibodies: 
 Rabbit Anti-GluA IgG   1:100 
 Rabbit Anti-GluA2&3 IgG   1:50 
 Mouse Anti-NR1 IgG    1:300 
 Rabbit Anti-NR2A&B IgG   1:100 
  
Secondary antibodies: 
 Goat anti-rabbit IgG    1:20 
 Goat anti-mouse IgG    1:20 
 
An incubation chamber was made by covering the bottom of a large petri dish with Parafilm 
on top of moistened filter paper, thus preventing the droplets to be applied from drying out 
during incubation. The protocol was performed according to Bergersen et al., 2008, as 
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followed:  
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2.5.5 Contrasting of ultrathin sections 
 
The sections were counterstained with 1% uranyl acetate and 0.3% lead citrate to make 
cellular compartments easier to differentiate. The uranyl acetate and lead citrate were pipetted 
into two separate eppendorf tubes and centrifuged for 5 minutes at 2000 rpm to make sure that 
any precipitates stayed at the bottom. The uranyl acetate was kept in the dark to avoid 
precipitation by covering the eppendorf tube with silver foil. The sections were incubated in 
30 μl droplets of 1% uranyl acetate for 10 minutes, before being rinsed 3x10 seconds in glass 
beakers with MQ water (exchanged the first beaker after three sections). The sections were 
then air dried at room temperature for 20 minutes. Managing one grid at a time, the sections 
were incubated in 30 μl of 0.3% lead citrate for 90 seconds, and then rinsed for 3x10 seconds 
in MQ water, before being put in the gridbox to air dry overnight. 
2.5.6 Electron microscopy 
 
All images were acquired by the use of a transmission electron microscope (CM10, Phillips, 
Germany) and the software program AnalySIS (AnalySIS Soft Imaging Systems Gmbh., 
Germany). An outline of the section was marked at a magnification of 360X for making it 
easier to find the right layers in the tissue. The cell body layer of stratum pyramidale was 
located at a magnification of 2500X before navigating to stratum radiatum, just beneath the 
cell bodies, were the large stem dendrites easily can be seen. Here, the magnification was 
increased to 46000X. Excitatory synapses that showed visible pre- and postsynaptic 
membranes, a synaptic cleft and a visible PSD with immunogold labelling were recorded. 
Approximately 50 synapses were recorded from each section. The images were given a scale 
bar of 500 nm before saving them as 8-bit TIFF files for later analysis. 
2.5.7 Image analysis 
 
The images were analyzed in ImageJ (Rasband, W.S., National Institute of Health, USA) by 
the use of the Synapse plug-in developed by Dr. Max Larsson: 
http://www.hu.liu.se/forskning/larsson-max/software?l=en. 
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The scale bar was used to obtain a scale of 0.9 pixels/nm. Outlines of the pre- and 
postsynaptic membranes and the PSD were highlighted, and observed gold particles were 
marked. The number of marked gold particles within 25 nm of the PSD was counted by the 
Synapse plug-in, representing the number of receptor subunits associated with the PSD 
(figure 2.3a and b). The PSD length was also measured. The PSD length and number of gold 
particles were averaged for each mouse and subsequently used to calculate the average for 
both the WT and mutUNG1 group. 
 
 
Figure 2.3 a) Electron micrograph of an excitatory synapse in stratum radiatum of CA1. The 
PSD can be seen as a black cloud because of all the proteins located here, making it electron 
dense. The black arrows indicate the lateral ends of the PSD, while the red arrows marks the 
gold particle. Gold particles within 25 nm of the postsynaptic membrane in the PSD were 
counted. t = presynaptic terminal, v = vesicles, m = mitochondrion, s = postsynaptic spine. b) 
Illustration of the lateral resolution that is obtained by the immunogold method. The colloidal 
gold particle is linked to the Fab fragment of the secondary antibody. Antigen is coloured in 
turquoise. 
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2.5.8 Statistical analysis 
 
The two-tailed student's t-test, where significance is presumed if P < 0.05, was used to 
compare the mutUNG1 group to the WT group. The F-test was used to see if equal variances 
could be assumed or not. The analyses were performed in GraphPad Prism 6 (GraphPad 
Software, inc., USA). 
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3 Results 
3.1 Gene expression 
 
The RNA used for cDNA conversion by reverse transcription was taken from whole 
hippocampus. The quality can be seen below in figure 3.1. The rightmost lane is a bit darker 
than the other lanes and had a marginally weaker band for the 16S rRNA. However, 
expression levels for GAPDH were the same in all six animals. The RNA in the other lanes 
seemed intact and did not show any sign of non-degraded genomic DNA. 
 
 
Figure 3.1 RNA separated by gel electrophoresis. Dark bands show 16S and 
28S rRNA. The lane furthest to the right (animal ID 49) shows a marginally 
weaker 16S band and a bit darker lane overall. 
 
 
qPCR was performed with specific primers for most subunits. Gene expression of AMPA 
receptor subunits GluA1, GluA2 and GluA3 and NMDA receptor subunits NR1, NR2A, 
NR2B, NR2D and NR3A were quantified in wild type and mutUNG1 expressing mice for 
comparison. Expression levels were normalized to GAPDH expression levels, as GAPDH 
were found to be equally expressed across all samples. The results are presented in figure 3.2. 
 
37 
 
 
Figure 3.2 Average gene expression levels for AMPA and NMDA receptor subunits in wild type and 
mutUNG1 expressing mice. The bar charts include standard deviations. 
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The P-values obtained by the Mann-Whitney U test were all higher than 0.05, indicating no 
significant difference (GluA1 = 0.10, GluA2 = 0.70, GluA3 = 0.70, NR1 = 0.70, NR2A = 
0.20, NR2B = 0.90, NR2D = 0.40, NR3A = 0.40). The high standard deviations observed are 
due to large variations within the two groups. 
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3.2 Western blot 
 
The immunoblots obtained by Western blotting on whole brain homogenate from a wild type 
mouse show a single, strong band for anti-GluA and GluA2&3 at the expected location, just 
above 100 kDa. NR1 did show a strong band at the expected location (~120 kDa), but also 
some weaker bands. However, these additional bands got weaker when reducing the 
concentration of antibody, while the expected band remained the same (other blots not shown 
here). NR2A&B showed one strong band at the expected location (~180 kDa), but also one 
strong band at ~60 kDa. 
 
 
 
Figure 3.3 Immunoblots for the four antibodies that were tested. 
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3.3 Immunogold electron microscopy 
 
Even though the qPCR analysis did not show any significant differences in gene expression 
between the wild type and mutUNG1 expressing mice, this did not mean that any differences 
at the protein level could be ruled out. Postembedding immunogold labelling in combination 
with electron microscopy were therefore performed.  
 
Ultrathin sections from the hippocampus of wild type and mutUNG1 expressing mice were 
labelled with antibodies for GluA1, GluA2&3, NR1 and NR2A&B. Excitatory synapses in 
the stratum radiatum of CA1 that showed immunogold labelling (figure 3.4) were recorded. 
The PSD lengths were measured, and the numbers of gold particles were quantified. Recorded 
synapses that did not contain gold particles within 25 nm of the PSD were excluded when 
analyzing the data. 
 
  
 
Figure 3.4 Two electron micrographs, one from wild type (left) and one from mutUNG1 (right), of 
excitatory synapses labelled with GluA2&3 antibodies. The black arrow heads enclose the length of 
the PSD, while red arrows point to gold particles. t = presynaptic terminal, v = vesicles, s = dendritic 
spine. The average number of gold particles and the average length of the PSD were compared 
between the two groups.  
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Gold particles were counted in PSDs of synapses that did show immunogold labelling (figure 
3.5). The F-test gave no significant difference for all the data sets, thus assuming equal 
variances, and the two-tailed student’s t-test was therefore used. The number of gold particles 
was very much the same in wild type and mutUNG1 expressing mice, and no statistical 
significance was observed with P-values above 0.05 in all the data sets (table 3.1). 
 
Figure 3.5 A graphical representation of the number of gold particles counted in PSDs of 
synapses showing immunogold labelling. No significant difference was found between wild 
type and mutUNG1 expressing mice. 
 
The length of the PSDs in the same synapses containing gold particles were measured (figure 
3.6). The F-test gave no statistical difference for all except the GluA1 data. The F-test for 
GluA1 gave a P-value of 0.0408, meaning that the variance between the two groups is 
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significantly different. The Welch’s two-tailed t-test, which does not assume equal variances, 
was therefore used to compare the PSD lengths of the two groups for GluA. The average PSD 
length of synapses labelled with anti-GluA2&3 did show a minor difference with 272 nm and 
293 nm in wild type and mutUNG1 expressing mice respectively. The other PSD lengths 
were very similar. The two-tailed student’s t-test showed no statistical differences, with P-
values above 0.05 in all the data sets (table 3.2). 
 
Figure 3.6 A graphical representation of the PSD length measured in wild type and mutUNG1 
expressing mice showing immunogold labelling. There was found no significant difference. The PSD 
length of synapses labelled with antibodies for AMPA receptor subunits proved to be longer than the 
PSD length of synapses labelled with antibodies for NMDA receptor subunits. 
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Number of gold particles in wild type  
and mutUNG1 expressing mice 
Antibody Group Gold particles P-value 
anti-GluA1 
Wild type 1.35 
0.37 
mutUNG1 1.30 
anti-Glua2&3 
Wild type 3.44 
0.40 
mutUNG1 3.20 
anti-NR1 
Wild type 1.73 
0.75 
mutUNG1 1.78 
anti-NR2A&B 
Wild type 1.50 
0.19 
mutUNG1 1.60 
 
Table 3.1 The number of gold particles recorded in synapses of wild type and mutUNG1 
expressing mice. No statistical significance was observed as all P-values were higher  
than 0.05. 
 
 
PSD length of wild type and mutUNG1 expressing mice 
Antibody Group PSD length, nm P-value 
anti-GluA1 
Wild type 270 
0.39 
mutUNG1 279 
anti-Glua2&3 
Wild type 272 
0.13 
mutUNG1 293 
anti-NR1 
Wild type 250 
0.67 
mutUNG1 252 
anti-NR2A&B 
Wild type 225 
0.56 
mutUNG1 230 
 
Table 3.2 The PSD lengths of wild type and mutUNG1 expressing mice. No statistical 
significance was observed as all P-values were higher than 0.05. 
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4 Discussion of methods 
4.1 Mouse as a model organism 
 
Mouse is a popular model organism used to study biological phenomena like gene function 
and diseases. It fulfills many of the criteria that a model organism should have, like size, a 
short generation time and production of many offspring. Mouse is a mammal and not far 
away, seen on an evolutionary timescale, from humans. We share almost the same set of 
genes and have very similar physiology and anatomy. The hippocampus is for example very 
similar between the species, although smaller in mice. 
 
Transgenic mice are genetically modified by adding foreign DNA into their genome, like was 
done for the creation of the mutUNG1 heart failure mouse (Lauritzen et al., 2014). The mouse 
was originally designed to study the effect of mitochondrial dysfunction in myocardiocytes, 
but it also allowed for the study of how a dysfunctional heart might affect the brain. 
4.2 Number of experimental animals 
 
The number of animals has an impact on the statistical data. Two groups of three mice in each 
(3 WT mice + 3 mutUNG1 mice) were used for the relative quantification of gene expression 
by qPCR. This is too few to assume a normalization of the data, and the student's t-test is 
therefore not usable. The Mann-Whitney U-test was therefore used as this test does not 
assume normalization. More animals will be needed to ensure confidence in the data. The data 
obtained were for that reason considered more as an indication. 
 
Two groups of six mice in each (6 WT mice + 6 mutUNG1 mice) were used for analyzing 
differences in glutamate receptor subunit expression at the protein level and PSD diameter by 
postembedding immunogold electron microscopy. The number of animals here was 
considered as sufficient for doing the student's t-test on the data acquired. 
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4.3 Quantitative polymerase chain reaction (qPCR) 
 
SYBR green is a fluorescent dye that binds double-stranded DNA (dsDNA) with great 
affinity. The increase in fluorescence is linear to the increase of DNA being amplified, 
making it a convenient tool for detection of PCR products. It can detect as few as 1-10 copies 
of a gene of interest. However, its advantage is also its disadvantage. The property of binding 
all dsDNA involves the risk of false positives if the sample is contaminated with unwanted 
DNA. Good and specific primers are therefore important to avoid primer-dimers and to ensure 
that only the gene of interest is amplified. 
 
No template controls were included to check for contamination, but also for primer-dimers. 
As cDNA is the only kind of DNA of interest here, the presence of genomic DNA (gDNA) is 
therefore unwanted. Presence of gDNA can be a problem if it contains pseudogenes with 
sequences complementary to the primers being used. The isolated RNA was therefore treated 
with DNase, an enzyme that degrades DNA, to prevent any DNA that might have been 
transferred along with the RNA from being amplified during qPCR. It should be mentioned 
that the qPCR setups did not include any -RT controls. A -RT control is made during the RT-
PCR setup by adding all reagents, but not the reverse transcriptase. After RT-PCR, it should 
therefore not contain any DNA as the RNA is not converted to cDNA. The solution is then 
used as -RT controls during qPCR. If the -RT control yields a fluorescent signal, it indicates a 
possible presence of gDNA. The lack of -RT controls must be considered a weakness of the 
qPCR setup used in this study, even though the presence of gDNA is very unlikely as the 
RNA was DNase-treated. The RNA was also checked for suspicious bands on an agarose gel 
and did not show any (figure 3.1). 
 
The standard curve method was, as previously mentioned, chosen as the method for analyzing 
the data. The standard curve method requires the least amount of optimization and validation 
compared to other methods. The most critical steps during setup are accurate dilution of 
samples and the pipetting when adding template to the SYBR green mixture. The latter was 
experienced to be particularly important when adding the most diluted template to the 
standard curves, as slight variances easily ruin the standard curve, making it unusable. 
 
GAPDH, β-Actin and 18S rRNA are popular reference genes as they are housekeeping genes 
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and should be stably expressed across all the samples. However, induced mutations might 
affect the gene expression, and it is therefore important to validate the expression levels 
before choosing a reference gene to go with (Kozera and Rapacz, 2013). Expression of 
GAPDH was clearly affected in myocardiocytes of the mutUNG1 heart failure mouse model, 
showing different expression levels across the mice being used, and β-Actin was found to be a 
better reference gene (Lauritzen et al., 2014). GAPDH was however not affected in 
hippocampal tissue of the same mice. In addition to normalizing the data, it also serves as a 
control for pipetting errors and variances between the individual sample's RT-PCR efficiency.  
4.4 Antibody specificity 
 
Using unspecific antibodies involves the risk of false positives since the antibodies might bind 
to several proteins, and not only the protein of interest, sharing a similar epitope. Antibody 
specificity is therefore crucial when performing post-embedding immunogold labelling. 
 
The specificity of primary antibodies was tested by western blotting. A specific antibody is 
expected to yield a single band on the immunoblot. However, it is difficult to avoid additional 
weaker bands completely as several factors can influence this, like too high protein and/or 
antibody concentrations, inefficient blocking and proteolytic breakdown of the antigen during 
homogenization. Anti-GluA1 and anti-GluA2&3 did show strong bands at the expected 
location and was assumed to be specific. Anti-NR2A&B did show one additional band, but 
this was thought to be a fragment, as this antibody has been proven specific by others before 
(Jensen et al., 2009). 
 
It is generally of interest to avoid the use of antibodies from the same organism as the 
organismal tissue it will be used with.  The NR1 antibody was made by mouse cells, but was 
chosen as no other usable antibody was found. In addition to the expected band, it did show 
some other bands. However, these bands got weaker when reducing the primary antibody 
concentration, while the expected band remained about the same. It was therefore presumed to 
be specific enough. A screening for the concentration to be used in the immunogold 
procedure was also performed, which did show labelling in the PSD and low background 
labelling. 
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As for the immunogold procedure, it should also be noted that proteins might be altered 
during fixation and embedding which may affect the specificity prior to incubation with 
antibodies (Amiry-Moghaddam and Ottersen, 2013). The freeze-embedding procedure with 
Lowicryl H2MO, however, preserves antigens to a greater degree compared to other 
embedding procedures (Bergersen et al., 2008). 
 
The specificity of secondary antibodies was confirmed by negative controls. The negative 
controls are sections subjected to the same experimental protocol as the other sections, but 
without incubation in primary antibodies. The sections should not contain any gold particles 
when looking in the electron microscope since there should be no primary antibodies for the 
secondary antibodies to bind to. 
4.5 Immunogold labelling efficiency 
 
The labelling efficiency of the immunogold method is defined as the ratio between the 
number of gold particles and the number of antigens present in the tissue (Mathiisen et al., 
2006). Several factors affect the labelling efficiency. Variations in the immunogold 
procedure, like antibody concentatrion, temperature fluctuations, rinsing and incubation time, 
will affect the efficiency, and is it therefore important that the sections to be compared have 
been treated as similarly as possible. Sections of wild type and mutUNG1 expressing mice, 
labelled with the same antibody, were therefore all included in the same run of the 
immunogold procedure. 
 
The choice of fixation medium affects not only tissue morphology, but also the labelling 
efficiency. The fixation medium used was a combination of formaldehyde and 
glutaraldehyde. Glutaraldehyde is a stronger protein cross-linker than formaldehyde, due to 
having more aldehyde groups for binding to the amino groups of proteins (Kiernan, 2000). It 
this therefore used to better preserve tissue morphology, but it can lower antibody binding. A 
low concentration of glutaraldehyde in the fixative is necessary to prevent the immunogold 
signal from being quenched when labelling for membrane proteins. 
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The choice of embedding medium will also affect labelling efficiency. Embedding in resin is 
done to prevent shrinkage of the tissue and being strong enough for the ultrathin sections 
required for electron microscopy (Hobot and Newman, 1996). Antigens might bind to the 
resin during the embedding procedure and thus reducing the labelling efficiency. However, 
Lowicryl HM20, a water-insoluble acryl-based resin, results in superior immunogold 
sensitivity by preserving the antigens to a large extent (Campagne et al., 1991; Bergersen et 
al., 2008). 
4.6 Background labelling 
 
It is difficult to avoid unspecific of the background completely, despite the antibodies 
showing specificity on western blot, because of the postembedding protocol itself (Bergersen 
et al., 2008). Unspecific labelling of is typically seen in structures which contain a high 
density of proteins, like the mitochondrial membrane. Like with the labelling efficiency in 
general, the background labelling is also affected by the same variables. Two different 
blocking solutions were used to prevent non-specific labelling as much as possible. The 
protein and ion concentrations in the blocking solutions can also be adjusted to affect 
labelling. 
4.7 Quantification of gold particles 
 
The colloidal gold particles used for post-embedding immunogold labelling are electron dense 
and can be seen at high magnification in the electron microscope. Even though electron 
microscopy yields a very high resolution, the lateral resolution of the immunogold procedure 
must be taken into account when analyzing the micrographs. The diameter of the gold 
particles used in this study was 10 nm, making the distance from the gold particle to the 
epitope approximately 25 nm (figure 2.3b). Gold particles located 25 nm away on either side 
of the postsynaptic membrane (in the PSD region) were therefore recorded. 
 
An advantage with the immunogold procedure is the equal probability of antibody binding to 
antigens on the section surface. It is should be noted that the amount of gold particles does not 
equal the number of antigens present in the tissue (Amiry-Moghaddam and Ottersen, 2013). 
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This is because of the previously mentioned factors affecting the labelling efficiency. 
However, there is an approximately linear relationship between the number of gold particles 
and available antigens (Ottersen, 1989). The amount of labelling can therefore be used to 
quantify the number of antigens present in the tissue. However, it is important to remember 
that the quantification is not absolute. 
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5 Discussion of results 
5.1 Gene expression 
 
The data obtained by qPCR showed there was a variable expression of mRNA for AMPA and 
NMDA receptor subunit within the two groups. This variance made it difficult to observe any 
difference, especially when working with a small sample size due to it being extra sensitive to 
variations within the data. The Mann-Whitney U test showed no significant difference for all 
the genes that were analyzed. 
 
Not all receptor subunits were analyzed. These include GluA4, NR2C and NR3B. CA1 
pyramidal neurons express AMPA receptors consisting mainly of GluA2 subunits in 
combination with either GluA3, but also GluA1 (Andersen et al., 2007, p. 254). NR2C is not 
significantly expressed in the adult hippocampus, and NR3B is not expressed at all. 
5.2 Immunogold electron microscopy 
 
The data obtained by immunogold labelling in combination with electron microscopy did not 
reveal any difference. However, the variance observed by qPCR was not found to be reflected 
at the protein level. The number of glutamate receptor subunits was very much the same in 
both groups. This was also the case for the PSD lengths. 
 
The average PSD lengths of those synapses that were labelled for AMPA receptor subunits 
were longer than the average PSD lengths of the synapses that were labelled for NMDA 
receptor subunits. This is in accordance with a previous study that showed a difference in 
PSD lengths of synapses containing only NMDA receptors (silent synapses) compared to 
synapses containing both NMDA and AMPA receptors in the Schaffer collateral pathway 
(Takumi et al., 1999). They did also show that the ratio of AMPA to NMDA is a linear 
function of the PSD length, and that AMPA receptor number drops to zero in PSDs shorter 
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than ~180 nm. It could be speculated that this is a consequence of LTP, where the insertion of 
AMPA receptors leads to a bigger PSD. 
 
Analysis of synapses did only include those synapses that showed immunogold labelling in 
their PSDs. There could be a difference in the number of synapses containing glutamate 
receptors if non-labelled synapses were included in the analysis. This means that a total 
change in the number of AMPA and NMDA receptors and/or receptor subunits cannot be 
excluded. 
 
An increase in the number of silent synapses is also possible. To investigate these synapses 
would require the sections to be labelled with two different antibodies (with different gold 
particle diameter for being able to visually separate the two), preferably against NR1 and 
GluA2 as these subunits are included in all AMPA and NMDA receptors in Schaffer 
collateral-CA1 synapses. 
5.3 Conclusion 
 
1. Variations in gene expression of AMPA and NMDA receptor subunits in the 
hippocampus were found in both groups of mutUNG1 expressing and wild type mice. 
However, no significant difference was found when comparing the two groups. 
 
2. No alterations in the number of AMPA and NMDA receptors and/or subunit 
composition were found in excitatory synapses of Schaffer collateral-CA1 synapses 
when comparing mutUNG1 expressing to wild type mice. 
 
3. No alterations in PSD length of Schaffer collateral-CA1 synapses containing 
immunogold labelling were found when comparing mutUNG1 expressing to wild type 
mice. The PSD length of synapses labelled for AMPA receptor subunits were longer 
than those labelled for NMDA receptor subunits. 
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The mutUNG1 expressing mouse model was originally created to study how mitochondrial 
dysfunction affects the cardiomyocytes of the heart. Average life expectancy after induction 
of mutUNG1 expression is approximately two months before they die of cardiac arrest. Even 
though no changes were observed when studying the brain of these mice, the possibility that 
such a short time period is not enough to affect the brain exists. The use of other animal 
models of cardiac dysfunction with a longer life expectancy might be better suited to show 
any consequences on brain function. Actually, in another study using a heart failure mouse 
model it was shown moderate impairment in spatial learning tasks in the Morris water maze 
(Hong et al., 2013). This moderate impairment was observed after three months of chronic 
HF, suggesting that the average life expectancy of two months of the mutUNG1 expressing 
mouse model is not a sufficient period of time for the HF condition to affect the brain. In 
addition, alterations in other brain areas cannot be ruled out. 
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Appendices 
Appendix A – Reagents and chemicals 
 
Chemical name Molecular formula Manufacturer 
Acetate CH3CO2H Sigma-Aldrich, USA 
Agarose C24H38O19  Sigma-Aldrich, USA 
Bovine serum albumine 
 
Fluka Chemica, 
Switzerland 
Bromophenol blue C19H10Br4O5S Sigma-Aldrich, USA 
Chloroform CHCl3 Sigma-Aldrich, USA 
Disodium phosphate Na2HPO4 Sigma-Aldrich, USA 
Dithioerythritol HSCH2CH(OH)CH(OH)CH2SH Sigma-Aldrich, USA 
Ethanol EtOH 
Arcus Kjemi AS, 
Norway 
Ethidium bromide C21H20BrN3 Sigma-Aldrich, USA 
Ethylenediaminetetraacetic 
acid C10H16N2O8 
Electron Microscopic 
Services, USA 
Glycine C2H5NO2 Sigma-Aldrich, USA 
Human serum albumin  Sigma-Aldrich, USA 
Hydrogen peroxide H2O2 
Fluka Chemica, 
Switzerland 
Isopropanol (CH3)2CHOH Sigma-Aldrich, USA 
Lead citrate Pb3(C6H5O7)2 
The British Drug 
Houses Ltd, Great 
Britain 
Nonidet-P40 (C2H4O)nC14H22O Sigma-Aldrich, USA 
Polyethylene glycol C15H16O2·C3H5ClO·(C2H4O)n·H2O]x Sigma-Aldrich, USA 
Protease inhibitor cocktail  Sigma-Aldrich, USA 
Sodium borohydride NaBH4 
Fluka Chemica, 
Switzerland 
Sodium chloride NaCl 
Fluka Chemica, 
Switzerland 
Sodium deoxycholate C24H39NaO4 Sigma-Aldrich, USA 
Sodium dihydrogen 
phosphate NaH2PO4 Sigma-Aldrich, USA 
Sodium dodecyl sulfate NaC12H25SO4 
Fluka Chemica, 
Switzerland 
Sodium hydroxide (2 M) NaOH Electron Microscopic 
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Services, USA 
Triton X-100 C14H22O(C2H4O)n (n=9-10) Sigma-Aldrich, USA 
Trizma base NH2C(CH2OH)3 Sigma-Aldrich, USA 
Trizma hydrochloride NH2C(CH2OH)3·HCl Sigma-Aldrich, USA 
Tween 20 C58H114O26 
Fluka Chemica, 
Switzerland 
Uranyl acetate UO2(CH3COO)2 
Fluka Chemica, 
Switzerland 
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Appendix B – Solutions 
Buffers 
 RIPA buffer: 25 mM Trizma HCl pH 7.6, 150 mM NaCl, 1% NP40, 0.1% SDS, 
0.5% Na deoxycholate and protease inhibitor cocktail (1 tablet). Store at 4 °C. 
 
 1% SDS buffer: 2.3 mg disodium hydrogen phosphate (Na2HPO4), 0.46 g 
monosodium phosphate (NaH2PO4), 2 g SDS, 2 tablets of protease inhibitor 
cocktail. Mix in 200 ml MQ water. 
 
 TAE buffer (50X): Mix 242 g Trizma base, 57.1 ml acetate and 100 ml of 0.5 M 
EDTA. Dilute 20 ml in 980 of MQ water for 1X TAE buffer. 
 
 Laemmli sample buffer (2X) w/ DTT: 20 ml 87% glycerol, 12.5 ml 1 M Trizma 
HCl, 4 g SDS, few grains of bromophenol blue. Add MQ water up to 100 ml. 
Adjust pH to 6.8. Store at room temperature. Add 10 µl of DTT to 40 µl of 
Laemmli sample buffer (2X). 
- 0.5 M Dithioerythritol (DTT): 39 mg in 0,5 ml MQ water. Store at 4 °C for up to 
one week. DTT reduces the disulfide bonds of proteins. 
 
 Running buffer (10X): 30.3 g 25mM Tris base, 144 g 192 mM glycine, 10 g 
SDS. Dissolve in 1 l of MQ water. 
 
 Blotting buffer (1X): 3.03 g 25mM Tris base, 14.4 g 192 mM glycine, 100 ml 
10% isopropanol. Dissolve in 1 l of MQ water. 
 
 Tris-buffered Saline w/ Tween (TBSTw): 7.9 g 10 mM Trizma HCl, 43.8 g 150 
mM NaCl, 2.5 ml 0.05% Tween 20. Dissolve in 5 l of MQ water. 
 
 0,1 M Phosphate buffer (PB): Dissolve 11.5 g disodium phosphate (Na2HPO4) 
and 2.3 g sodium dihydrogen phosphate (NaH2PO4) in 1 L of MQ water. Adjust 
pH to 7.4. 
 
 0,05 M Tris buffer: Dissolve 0.97 g Trizma base (NH2C(CH2OH)3) and 6.61 
Trizma HCl (NH2C(CH2OH)3HCl) in 1 L of MQ water. Adjust pH to 7.4. 
 
 Tris Buffered Saline Triton (TBST): Mix 100 ml 0.05 M Tris buffer, 900 ml 
0.3% NaCl and 1 ml Triton X-100-0.1%. 
- 0.3% NaCl: Dissolve 3 g NaCl in 1 L of MQ water. 
 
Etching solution 
 2% Hydrogen Peroxide (immunogold): Mix 40 µl 30% H2O2 with 560 mL of 
PB. 
 
Blocking solutions 
 4% Bovine Serum Albumin (Western blot): Dissolve 4 g of BSA in 100 ml of 
TBSTw. Make fresh before each procedure. 
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 1% Bovine Serum Albumin (Western blot): Dissolve 1 g of BSA in 100 ml of 
TBSTw. Make fresh before each procedure. 
 
 Borohydride/Glycine solution (immunogold): Dissolve 37 mg glycine and 10 
mg Na-borohydride in 10 ml of TBST. Make fresh before each procedure. 
 
 2% Human serum albumin (immunogold): Dissolve 60 mg HSA in 3 ml TBST. 
Make fresh before each procedure. 
 
 2% Human serum albumin w/ PEG (immunogold): Add 25 mg polyethylene 
glycol (PEG) to 50 ml of TBST. Store at 4 °C. Dissolve 60 mg HSA in 3 ml of this 
TBST w/ PEG. Make fresh before each procedure. 
 
Contrasting solutions 
 1% Uranyl acetate (immunogold): The reagents needed for this solution are 
toxic and must therefore be mixed in a fume hood. Mix 5 g of uranyl acetate and 
40 ml of ethanol with 60 ml of pre-boiled MQ water. Cover the solution and place 
it on an electric shaker for the uranyl acetate to dissolve completely. Filter the 
solution and store at 4 °C in the dark. 
 
 0.3% Lead citrate (immunogold): This must be carried out in a fume hood in 
order to protect the solution from CO2, which otherwise may cause precipitation. 
Mix 0.15 g of lead citrate with 48 ml of pre-boiled MQ water. Add 2.5 ml of 2 M 
sodium hydroxide and place the solution on a magnetic stirrer plate. After 
sufficient mixing transfer the solution to an airtight container and store at 4 °C. 
Appendix C – Kits 
 RNeasy Lipid Tissue Mini Kit (QIAGEN, Netherlands): Contains mini spin 
columns, collection tubes, buffers, RNase-free water and QIAzol Lysis Reagent 
(contains phenol/guanidine, optimized for lysis of fatty tissue). 
 
 High Capacity RNA-to-cDNA kit (Applied Biosystems, USA): Contains 20X 
Enzyme mix (MuLV and RNase inhibitor protein and 2X RT Buffer Mix (includes 
dNTPs, random octamers, and oligo dT-16). 
 
 SYBR® Green PCR Master Mix (Applied Biosystems, USA): contains SYBR 
Green 1 Dye, AmpliTaq Gold® DNA Polymerase, dNTPs with dUTP, Passive 
Reference 1, and optimized buffer components. 
 
 BCA Protein Assay Kit (Pierce, Thermo Scientific, USA): Contains BCA reagent 
A (bicinchoninic acid and sodium cabonate), BCA reagent B (cupric (II) sulfate) 
and bovine serum albumin standards. 
 
 SuperSignal® West Dura Extended Duration Substrate kit (Pierce, Thermo 
Scientific, USA): luminol-based enhanced chemiluminescence (ECL) HRP 
substrate 
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Appendix D – Antibodies 
 
PRIMARY ANTIBODIES 
 
Antibody Host Class Type Antigen Application Company Catalogue # Lot # 
 
Anti-GluA1 
 
Rabbit  
 
IgG 
 
Polyclonal 
 
Cytoplasmic site of 
the receptor 
 
WB, EM 
 
Millipore 
 
AB1504 
 
LV1519
2215 
 
Anti-GluA2&3 
 
Rabbit  
 
IgG 
 
Polyclonal 
 
C-terminus 
 
WB, EM 
 
Millipore 
 
AB1506 
 
LV1583
031 
 
Anti-NR1 
 
Mouse 
 
IgG 
 
Monoclonal 
 
Extracellular loop 
between 
transmembrane 
regions III & IV 
 
WB, EM 
 
Millipore 
 
MAB363 
 
2219311 
 
Anti-NR2A&B 
 
Rabbit  
 
IgG 
 
Polyclonal 
 
C-terminus 
 
WB, EM 
 
Millipore 
 
AB1548 
 
LV1488
6500 
 
SECONDARY ANTIBODIES 
 
Antibody Host Class Type Antigen Application Company Catalogue # Lot # 
 
ECL
TM
 Anti-
rabbit IgG, 
HRP-linked 
 
Donkey 
 
 IgG 
 
Polyclonal 
 
Rabbit IgG 
 
WB 
 
GE 
Healthcare 
 
NA934 
 
337576 
 
Anti-mouse 
IgG –  
Peroxidase 
 
Rabbit  
 
IgG 
 
Polyclonal 
 
Mouse IgG 
 
WB 
 
Sigma-
Aldrich 
 
A9044 
 
010M47
97 
 
Anti Rabbit 
IgG 10nm 
Gold 
 
Goat 
 
F(ab)2 
 
Polyclonal 
 
Rabbit IgG 
 
EM 
 
BBI 
Solutions 
 
EM GFAR10 
 
15617 
 
Anti Mouse 
IgG Fc 
Specific 10nm 
Gold 
 
Goat 
 
IgG 
 
Polyclonal 
 
Mouse IgG Fc 
 
EM 
 
BBI 
Solutions 
 
EM GAM10 
 
14712 
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Appendix E – qPCR data 
 
 GluA1  
Wild type (ID #) Normalized value Average 
6 0.154577 
0.162816 33 0.119011 
39 0.214858 
mutUNG1 (ID #) Normalized value Average 
4 0.114341 
0.100295 98 0.080788 
42 0.105756 
 
 GluA2  
Wild type (ID #) Normalized value Average 
6 1.089693 
1.020089 33 0.650834 
39 1.319742 
mutUNG1 (ID #) Normalized value Average 
4 0.86882 
0.906244 98 0.821434 
42 1.028479 
 
 GluA3  
Wild type (ID #) Normalized value Average 
6 1.232039 
1.508236 33 1.68329 
39 1.609379 
mutUNG1 (ID #) Normalized value Average 
4 1.004668 
1.82057 98 2.504993 
42 1.952049 
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 NR1  
Wild type (ID #) Normalized value Average 
6 0.938058 
0.930265 33 0.837948 
39 1.01479 
mutUNG1 (ID #) Normalized value Average 
4 0.617164 
0.889565 98 0.685691 
42 1.36584 
 
 NR2A  
Wild type (ID #) Normalized value Average 
6 1.221483 
1.182984 33 0.875489 
39 1.45198 
mutUNG1 (ID #) Normalized value Average 
4 0.677222 
0.754718 98 0.465993 
42 1.120939 
 
 NR2B  
Wild type (ID #) Normalized value Average 
6 0.093228 
0.108537 33 0.104514 
39 0.127976 
mutUNG1 (ID #) Normalized value Average 
4 0.028526 
0.088955 98 0.09969 
42 0.138649 
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 NR2D  
Wild type (ID #) Normalized value Average 
6 0.076323 
0.081953 33 0.102965 
39 0.066571 
mutUNG1 (ID #) Normalized value Average 
4 0.027063 
0.064693 98 0.081893 
42 0.085123 
 
 NR3A  
Wild type (ID #) Normalized value Average 
6 0.921028 
1.13708 33 1.372871 
39 1.117343 
mutUNG1 (ID #) Normalized value Average 
4 0.356473 
0,956055 98 1.369994 
42 1.141697 
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Appendix F – Protein quantification 
 
Absorbance measured at 562 nm 
    
       Protein, 
      μg/ml Abs. Abs. Abs. Abs. 
  0 0.125 0.114 0.116 0.145 
  20 0.171 0.160 0.160 0.192 
  100 0.208 0.201 0.197 0.225 
  250 0.316 0.298 0.316 0.335 
  500 0.463 0.498 0.438 0.452 
  750 0.596 0.596 0.587 0.604 
  1000 0.736 0.748 0.726 0.735 
  2000 1.188 1.097 1.257 1.211 
  
       
 
 
      
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       Dilution of protein 
homogenate with 
    
Protein ug/ul 
1% SDS buffer Abs. Abs. Abs. Abs. in hom. in hom. 
1:5 -> 1.747 1.741 1.718 1.781 3152.33 15.76 
1:10 -> 1.041 1.034 1.045 1.045 1741.67 17.42 
1:20 -> 0.688 0.663 0.723 0.678 1035 20.70 
       
     
Average:  18 ug/ul 
 
      Dilution of protein homogenate for SDS-PAGE: 
   Dilute prot. hom. 1:9 with sample buffer to obtain a final concentration 2 ug/ul.  
y = 0.0005x + 0.1705 
R² = 0.9921 
0,000
0,200
0,400
0,600
0,800
1,000
1,200
1,400
0 500 1000 1500 2000 2500
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Appendix G – Immunogold electron microscopy data 
         
 
WT 6233 
 
WT 6234 
 
WT 6235 
 
n = 39 synapses 
 
n = 45 synapses 
 
n = 35 synapses 
         
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
         Average: 257.85 1.21   266.55 1.49   265.65 1.34 
Standard deviation: 79.65 0.41 
 
55.51 0.79 
 
75.11 0.64 
Average deviation: 57.63 0.33   45.70 0.65   59.06 0.51 
Max: 556.58 2.00 
 
386.74 4.00 
 
440.91 3.00 
Min: 106.57 1.00   160.80 1.00   147.89 1.00 
         
         
 
WT 6236 
 
WT 6237 
 
WT 6238 
 
n = 44 synapses 
 
n = 39 synapses 
 
n = 47 synapses 
         
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
         Average: 280.95 1.25   277.70 1.31   268.84 1.51 
Standard deviation: 90.59 0.58 
 
65.19 0.73 
 
78.25 1.06 
Average deviation: 72.66 0.41   48.54 0.50   60.62 0.72 
Max: 560.86 3.00 
 
481.70 4.00 
 
498.28 7.00 
Min: 151.32 1.00   143.47 1.00   99.77 1.00 
 
Table A.1 A summary of the synapses analyzed in wild type mice labeled with antibodies for GluA1. 
68 
 
 
         
 
mutUNG1 6239 
 
mutUNG1 6240 
 
mutUNG1 6241 
 
n = 38 synapses 
 
n = 38 synapses 
 
n = 44 synapses 
         
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
         Average: 320.48 1.26   247.09 1.24   270.52 1.32 
Standard deviation: 93.51 0.55 
 
62.71 0.59 
 
63.76 0.64 
Average deviation: 72.73 0.42   51.80 0.39   52.91 0.48 
Max: 537.31 3.00 
 
369.96 4.00 
 
406.08 4.00 
Min: 183.44 1.00   108.93 1.00   161.67 1.00 
         
         
 
mutUNG1 6242 
 
mutUNG1 6243 
 
mutUNG1 6244 
 
n = 41 synapses 
 
n = 39 synapses 
 
n = 45 synapses 
         
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
         Average: 278.25 1.37   281.02 1.28   276.94 1.33 
Standard deviation: 68.70 0.80 
 
69.95 0.65 
 
57.01 0.64 
Average deviation: 54.47 0.55   53.06 0.45   45.42 0.49 
Max: 428.40 5.00 
 
479.14 4.00 
 
409.64 4.00 
Min: 145.66 1.00   139.28 1.00   153.23 1.00 
 
Table A.2 A summary of the synapses analyzed in mutUNG1 expressing mice labeled with antibodies for GluA1. 
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WT 6233 
 
WT 6234 
 
WT 6235 
 
n = 42 synapses 
 
n = 55 synapses 
 
n = 50 synapses 
         
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
         Average: 258.20 3.37   252.87 2.83   247.40 3.02 
Standard deviation: 65.15 2.48 
 
60.95 1.72 
 
61.32 1.86 
Average deviation: 54.58 2.04   47.75 1.26   47.05 1.26 
Max: 371.04 10.00 
 
417.61 8.00 
 
432.67 8.00 
Min: 105.55 1.00   134.92 1.00   126.97 1.00 
         
         
 
WT 6236 
 
WT 6237 
 
WT 6238 
 
n = 51 synapses 
 
n = 54 synapses 
 
n = 51 synapses 
         
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
         Average: 265.98 3.24   294.43 4.00   314.87 4.15 
Standard deviation: 54.64 1.76 
 
82.65 2.28 
 
95.78 2.70 
Average deviation: 45.67 1.43   66.14 1.90   77.80 2.05 
Max: 365.58 7.00 
 
487.84 9.00 
 
579.69 14.00 
Min: 148.07 1.00   144.67 1.00   159.22 1.00 
 
Table A.3 A summary of the synapses analyzed in wild type mice labeled with antibodies for GluA2&3. 
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mutUNG1 6239 
 
mutUNG1 6240 
 
mutUNG1 6241 
 
n = 40 synapses 
 
n = 47 synapses 
 
n = 50 synapses 
         
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
         Average: 301.59 3.15   281.27 3.23   301.37 2.70 
Standard deviation: 84.00 2.24 
 
90.42 2.62 
 
76.93 1.51 
Average deviation: 68.30 1.90   79.41 1.93   62.14 1.35 
Max: 474.51 7.00 
 
443.65 13.00 
 
485.97 5.00 
Min: 170.48 1.00   108.78 1.00   149.25 1.00 
         
         
 
mutUNG1 6242 
 
mutUNG1 6243 
 
mutUNG1 6244 
    
n = 45 synapses 
 
n = 49 synapses 
         
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
         Average: - -   297.70 3.43   283.90 3.48 
Standard deviation: - - 
 
81.63 2.35 
 
75.31 2.16 
Average deviation: - -   65.33 1.91   57.18 1.72 
Max: - - 
 
469.71 10.00 
 
485.47 8.00 
Min: - -   145.19 1.00   153.40 1.00 
 
Table A.4 A summary of the synapses analyzed in mutUNG1 expressing mice labeled with antibodies for GluA2&3. mutUNG1 6242 has no data because 
the section did not contain the CA1 area. 
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WT 6233 
 
WT 6234 
 
WT 6235 
 
n = 41 synapses 
 
n = 51 synapses 
 
n = 45 synapses 
         
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
         Average: 247.61 1.61   239.03 1.68   246.95 1.78 
Standard deviation: 61.90 0.95 
 
55.08 1.13 
 
59.44 1.19 
Average deviation: 50.02 0.68   43.14 0.77   46.77 0.80 
Max: 396.76 6.00 
 
416.64 7.00 
 
411.88 7.00 
Min: 133.53 1.00   134.22 1.00   112.12 1.00 
         
         
 
WT 6236 
 
WT 6237 
 
WT 6238 
 
n = 46 synapses 
 
n = 46 synapses 
 
n=47 synapses 
         
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
         Average: 252.42 2.00   257.76 1.73   254.53 1.56 
Standard deviation: 66.10 1.20 
 
51.07 0.90 
 
77.89 0.87 
Average deviation: 53.73 0.83   40.79 0.71   57.68 0.74 
Max: 382.42 6.00 
 
382.33 4.00 
 
500.16 4.00 
Min: 130.44 1.00   176.32 1.00   144.27 1.00 
 
Table A.5 A summary of the synapses analyzed in wild type mice labeled with antibodies for NR1. 
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mutUNG1 6239 
 
mutUNG1 6240 
 
mutUNG1 6241 
 
n = 47 synapses 
 
n = 47 synapses 
 
n = 47 synapses 
         
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
         Average: 268.25 1.59   249.18 2.07   249.90 1.34 
Standard deviation: 69.07 0.71 
 
76.32 1.35 
 
82.37 0.69 
Average deviation: 58.14 0.63   53.65 0.99   65.06 0.52 
Max: 414.51 3.00 
 
464.51 6.00 
 
494.34 4.00 
Min: 152.87 1.00   112.88 1.00   158.05 1.00 
         
         
 
mutUNG1 6242 
 
mutUNG1 6243 
 
mutUNG1 6244 
 
n = 45 synapses 
 
n = 47 synapses 
 
n = 46 synapses 
         
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
         Average: 246.15 2.12   244.57 2.02   252.02 1.51 
Standard deviation: 66.85 1.12 
 
71.33 1.25 
 
59.66 0.68 
Average deviation: 48.74 0.81   56.28 0.96   49.49 0.57 
Max: 474.79 6.00 
 
455.38 6.00 
 
371.77 4.00 
Min: 142.74 1.00   126.58 1.00   142.93 1.00 
 
Table A.6 A summary of the synapses analyzed in mutUNG1 expressing mice labeled with antibodies for NR1. 
 
 
73 
 
         
 
WT 6233 
 
WT 6234 
 
WT 6235 
 
n = 42 synapses 
 
n = 49 synapses 
 
n = 54 synapses 
         
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
         Average: 240.57 1.50   216.35 1.49   216.62 1.61 
Standard deviation: 52.77 0.71 
 
51.63 0.74 
 
54.35 0.70 
Average deviation: 38.19 0.60   38.91 0.62   40.90 0.62 
Max: 405.58 4.00 
 
389.43 4.00 
 
364.38 3.00 
Min: 158.22 1.00   131.65 1.00   139.70 1.00 
         
         
 
WT 6236 
 
WT 6237 
 
WT 6238 
 
n = 44 synapses 
 
n = 48 synapses 
 
n = 47 synapses 
         
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
         Average: 229.28 1.41   212.94 1.50   236.52 1.50 
Standard deviation: 67.08 0.69 
 
43.51 0.82 
 
71.03 0.66 
Average deviation: 53.27 0.58   31.06 0.66   52.62 0.59 
Max: 383.83 3.00 
 
365.17 4.00 
 
452.49 3.00 
Min: 102.54 1.00   137.25 1.00   107.41 1.00 
 
Table A.7 A summary of the synapses analyzed in wild type mice labeled with antibodies for NR2A&B. 
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mutUNG1 6239 
 
mutUNG1 6240 
 
mutUNG1 6241 
 
n = 48 synapses 
 
n = 46 synapses 
 
n = 51 synapses 
         
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
         Average: 224.36 1.43   215.02 1.45   253.27 1.61 
Standard deviation: 63.49 0.70 
 
56.49 0.66 
 
69.36 1.02 
Average deviation: 52.55 0.59   43.96 0.56   55.98 0.81 
Max: 374.81 3.00 
 
396.02 4.00 
 
419.22 5.00 
Min: 134.17 1.00   115.41 1.00   147.18 1.00 
         
         
 
mutUNG1 6242 
 
mutUNG1 6243 
 
mutUNG1 6244 
 
n = 51 synapses 
 
n = 50 synapses 
 
n = 53 synapses 
         
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
 
PSD length, 
nm 
Gold 
particles 
         Average: 225.44 1.60   222.25 1.63   238.70 1.86 
Standard deviation: 64.82 1.00 
 
57.11 0.82 
 
53.75 0.83 
Average deviation: 51.78 0.73   41.80 0.70   40.92 0.64 
Max: 431.51 6.00 
 
369.61 4.00 
 
404.64 4.00 
Min: 134.51 1.00   117.33 1.00   149.69 1.00 
 
Table A.8 A summary of the synapses analyzed in mutUNG1 expressing mice labeled with antibodies for NR2A&B. 
 
